番茄社区app

Gastroenterology >

Irritable Bowel Syndrome

News, opinions and meeting coverage in gastroenterology.

AANP: Treatment for IBS Includes Education, Reassurance, and Medication

INDIANAPOLIS -- Although the recent withdrawal of tegaserod from the market has left a hole in the options available to treat irritable bowel syndrome (IBS), there are still many available.

Heart Risk Prompts FDA to Pull IBS Agent Tegaserod (Zelnorm)

ROCKVILLE, Md. -- The FDA said today that Novartis has halted sales of tegaserod (Zelnorm), its agent for irritable bowel syndrome and constipation, following suggestions of a small increase in ischemic events, including angina and stroke, in those taking the drug.

DDW: Constipation Drug Seen Safe and Effective for Long Term Use in Elderly

Los Angeles 芒鈧€� The new medication Amitiza (lubiprostone) is safe and effective as long-term therapy for chronic constipation in older patients, researchers reported here. Results were at least as good in seniors as in the more general populations studied earlier.

ACP: A Look at What Works in Chronic Constipation

PHILADELPHIA, April 7 - New drug therapies are coming on the market to treat chronic constipation, but it is instructive to examine some of the older approaches and therapies to see what works and what doesn't.

ACP: Causes of Constipation and Tips for Office Evaluation

PHILADELPHIA - Patients frequently complain of constipation to their physicians, but they and the doctors may be speaking at cross purposes. In a survey of patients and specialist and resident physicians, 50% of the time patient responses disagreed with physicians' answers about what is constipation.